R Latini

Summary

Affiliation: Istituto di Ricerche Farmacologiche Mario Negri
Country: Italy

Publications

  1. ncbi request reprint Relationship between post-cardiac arrest myocardial oxidative stress and myocardial dysfunction in the rat
    Fernanda Schäfer Hackenhaar
    IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    J Biomed Sci 21:70. 2014
  2. ncbi request reprint Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial
    Roberto Latini
    Department of Cardiovascular Research, IRCCS Instituto Mario Negri, Milano, Italy Electronic address
    Am Heart J 166:935-40.e1. 2013
  3. pmc Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial
    Marcello Disertori
    Department of Cardiology, Santa Chiara Hospital, Trento, Italy
    BMC Cardiovasc Disord 13:28. 2013
  4. ncbi request reprint Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials
    Roberto Latini
    Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, Via Giuseppe La Masa 19, 20156 Milan, Italy
    Eur J Heart Fail 14:992-9. 2012
  5. ncbi request reprint Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-atrial fibrillation trial
    R Latini
    Istituto di Ricerche Farmacologiche Mario Negri, Milan Istituti Ospitalieri, Cremona POL Madonna della Consolazione, Reggio Calabria, Italy
    J Intern Med 269:160-71. 2011
  6. ncbi request reprint Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting
    R Latini
    Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy
    J Am Coll Cardiol 35:1801-7. 2000
  7. ncbi request reprint Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study
    G Zuanetti
    Istituto Mario Negri, Milano, Italy
    Circulation 96:4239-45. 1997
  8. ncbi request reprint Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial
    R Latini
    Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea, 62 20157 Milan, Italy
    Heart Dis 2:185-90. 2000
  9. ncbi request reprint High-sensitivity cardiac troponin T for detection of subtle abnormalities of cardiac phenotype in a general population of elderly individuals
    S Masson
    Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    J Intern Med 273:306-17. 2013
  10. ncbi request reprint Left ventricular response to beta-adrenergic stimulation in aging rats
    S Masson
    Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    J Gerontol A Biol Sci Med Sci 55:B35-41; discussion B42-3. 2000

Detail Information

Publications11

  1. ncbi request reprint Relationship between post-cardiac arrest myocardial oxidative stress and myocardial dysfunction in the rat
    Fernanda Schäfer Hackenhaar
    IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    J Biomed Sci 21:70. 2014
    ..Hearts were also harvested for measurement of tissue IsoP and 8-OHG. Myocardial function was assessed by echocardiography at the corresponding time points. Additional 8 rats were not subjected to CA and served as baseline controls...
  2. ncbi request reprint Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial
    Roberto Latini
    Department of Cardiovascular Research, IRCCS Instituto Mario Negri, Milano, Italy Electronic address
    Am Heart J 166:935-40.e1. 2013
    ..Therefore, it was of interest to assess risk factors for incident AF in a large, representative population of patients with cardiovascular risk factors and impaired glucose tolerance but not overt diabetes in NAVIGATOR...
  3. pmc Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial
    Marcello Disertori
    Department of Cardiology, Santa Chiara Hospital, Trento, Italy
    BMC Cardiovasc Disord 13:28. 2013
    ..Few data on the thromboembolic (TE) risk of paroxysmal and persistent atrial fibrillation (AF) are available. This study aimed to assess the incidence of TE events in paroxysmal and persistent AF...
  4. ncbi request reprint Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials
    Roberto Latini
    Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, Via Giuseppe La Masa 19, 20156 Milan, Italy
    Eur J Heart Fail 14:992-9. 2012
    ..Since the role of inflammation in the progression of chronic heart failure (HF) is debated, we investigated the prognostic value of PTX3 and the effect of a statin in two large populations of patients with HF...
  5. ncbi request reprint Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-atrial fibrillation trial
    R Latini
    Istituto di Ricerche Farmacologiche Mario Negri, Milan Istituti Ospitalieri, Cremona POL Madonna della Consolazione, Reggio Calabria, Italy
    J Intern Med 269:160-71. 2011
    ..we evaluated the prognostic role of circulating cardiovascular biomarkers in patients with a history of recent atrial fibrillation (AF)...
  6. ncbi request reprint Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting
    R Latini
    Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy
    J Am Coll Cardiol 35:1801-7. 2000
    ..We sought to determine whether the clinical effects of early angiotensin-converting enzyme (ACE) inhibitor (ACEi) treatment for acute myocardial infarction (MI) are influenced by the concomitant use of aspirin (ASA)...
  7. ncbi request reprint Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study
    G Zuanetti
    Istituto Mario Negri, Milano, Italy
    Circulation 96:4239-45. 1997
    ..We evaluated whether treatment with an ACE inhibitor begun within 24 hours from the onset of symptoms is able to decrease mortality and morbidity of diabetic patients with acute MI...
  8. ncbi request reprint Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial
    R Latini
    Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea, 62 20157 Milan, Italy
    Heart Dis 2:185-90. 2000
    ..Lisinopril is safe and effective when given early after the onset of myocardial infarction, regardless of a concomitant administration of ASA started early and continued over a 6-week period...
  9. ncbi request reprint High-sensitivity cardiac troponin T for detection of subtle abnormalities of cardiac phenotype in a general population of elderly individuals
    S Masson
    Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    J Intern Med 273:306-17. 2013
    ..To investigate the association between circulating cardiac biomarkers and minor abnormalities in cardiac phenotype [left ventricular (LV) mass and midwall fractional shortening (MFS)] in elderly individuals in a general population sample...
  10. ncbi request reprint Left ventricular response to beta-adrenergic stimulation in aging rats
    S Masson
    Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    J Gerontol A Biol Sci Med Sci 55:B35-41; discussion B42-3. 2000
    ....
  11. ncbi request reprint Cardiac protection by pharmacological modulation of inflammation
    R Latini
    Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy
    Expert Opin Investig Drugs 10:1913-24. 2001
    ..Similarly, results of trials aimed at preventing cardiovascular events by eradicating chronic infections will be among the first to directly test whether such therapies will decrease risks of cardiovascular disease...